INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
51 hedge funds and large institutions have $30.2M invested in Infinity Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
51
Holding in Top 10
–
Calls
$37K
Puts
–
Top Buyers
| 1 | +$123K | |
| 2 | +$19.9K | |
| 3 | +$11K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$10K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3K |
Top Sellers
| 1 | -$900K | |
| 2 | -$728K | |
| 3 | -$90.2K | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$76K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$54.6K |